Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Is Nokia Corporation (ADR) (NOK) Preparing for a Smartphone Backlash?

At its latest handset introduction, Nokia Corporation (ADR) (NYSE:NOK) seemed to be bucking the phone-making industry trend of showing off whatever is a company’s splashiest high-end product and instead taking the low and middle roads.

In other words, instead of hyping its latest state-of-the-art smartphones at the Mobile World Congress in Barcelona, Spain, Nokia brought out four realistically priced state-of-the-wallet devices. And only two of them were smartphones.

Nokia Corporation (ADR) (NYSE:NOK)

Nokia’s new mid-market 3G smartphones are the Lumia 720 and Lumia 520. They both run Microsoft Corporation (NASDAQ:MSFT)‘s Windows Phone 8 operating system. The main differences between them are display size, camera resolution, battery life, and price: $331 for the 720, and $185 for the 520.

For comparison, a top-of-the-line 4G LTE Lumia 920 was priced at $836 at the time of its introduction.

Nokia plans on rolling out these two phones first in Hong Kong and Vietnam (and Singapore for the 720) by the end of the first quarter of 2013 before bringing them to China, Europe, the rest of Asia, Africa, and India. It did not mention bringing them to the U.S.

For the two much less expensive phones Nokia announced at the Mobile World Congress, the Nokia 301 and the 105, the company obviously has taken to heart the sales figures of its Asha line of feature phones versus those of its Lumia smartphones. For the fourth quarter, Nokia sold 9.3 million Asha phones compared to 4.4 million Lumias.

The 301 and 105 are supposed to give what the company called “aspirational Lumia experiences” for first-time cell phone buyers, and Nokia is making sure that buyers can afford these stepping stone handsets. The 105, a feature phone, is priced at $20 — and that’s retail, not a subsidized price. The 301, a feature phone that can stream video, is priced at $86.

Nokia said first markets for the 105 would be China, Egypt, India, Indonesia, Nigeria, Russia, and Vietnam, before expanding to the rest of the world.

Nokia’s re-emphasis on the lower end of the cell phone market comes after it saw its own smartphone sales fall 53.6% in 2012 over the previous year. If it can’t be totally competitive with Apple Inc. (NASDAQ:AAPL) and the Android phone makers like Samsung, then it’s got to get back to what made it once the world’s largest cell phone maker: selling basic phones in the emerging markets.

Nokia’s been struggling in a world of Apple and Android smartphone dominance. However, the company has banked its future on its next generation of Windows smartphones. Motley Fool analyst Charly Travers has created a new premium report that digs into both the opportunities and risks facing Nokia to help investors decide if the company is a buy or sell. To get started, simply click here now.

The article Is Nokia Preparing for a Smartphone Backlash? originally appeared on and is written by Dan Radovsky.

Fool contributor Dan Radovsky has no position in any stocks mentioned. The Motley Fool recommends Apple. The Motley Fool owns shares of Apple and Microsoft. Try any of our Foolish newsletter services free for 30 days. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy.

Copyright © 1995 – 2013 The Motley Fool, LLC. All rights reserved. The Motley Fool has a disclosure policy.

Biotech Stock Alert - 20% Guaranteed Return in One Year

Hedge Funds and Insiders Are Piling Into

One of 2015's best hedge funds and two insiders snapped up shares of this medical device stock recently. We believe its transformative and disruptive device will storm the $3+ billion market and help it achieve 500%-1000% gains in 3 years.

Get your FREE REPORT and the details of our 20% return guarantee today.

Subscribe me to Insider Monkey's Free Daily Newsletter
This is a FREE report from Insider Monkey. Credit Card is NOT required.
Loading Comments...

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 102% in 3 years!! Wondering How?

Download a complete edition of our newsletter for free!